Technology 31 May 2026 Daily Monitor (Uganda)
Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial
Global trial comparing ivonescimab to Keytruda expected to aid US approval. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/akeso-lung-cancer-drug-helps-patients-live-15-longer-than-immunotherapy-in-china-trial-5480036
Global trial comparing ivonescimab to Keytruda expected to aid US approval. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/akeso-lung-cancer-drug-helps-patients-live-15-longer-than-immunotherapy-in-china-trial-5480036